We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Prevalence and Treatment of Von Willebrand Disease- Related Menorrhagia in Adolescents: A Review.
- Authors
Mikhail, Sameh; Kouides, Peter
- Abstract
Heavy menstrual bleeding is a fairly common problem among women of reproductive age and a frequent complaint among adolescents. The pathophysiological mechanisms that cause menorrhagia in adolescents are different than those that cause menorrhagia in older women. Compared with the adult menorrhagia population, there have been far fewer studies about the prevalence of bleeding disorders and the efficacy of different treatment strategies in adolescents with menorrhagia. Excessive menstrual bleeding caused by bleeding disorders results in hospitalizations, administration of blood products, time lost from school and other activities, and decreased quality of life. Moreover, managing menorrhagia in patients with undiagnosed disorders of hemostasis may be associated with unwanted risks and complications. The studies evaluating the prevalence of Von Willebrand disease (VWD) in adolescents with menorrhagia identified over 500 patients with a prevalence range from 3% to 36%, depending on the clinical setting studied. The highest prevalence is seen in adolescents referred to an outpatient hemophilia center, whereas the lowest is seen in the acute hospital setting. Treatment of VWD is often complex, requiring a combination of therapies. Furthermore, different subtypes of VWD respond differently to treatment. There are three main hemostatic agents used to stop and/or prevent bleeding at the time of hemostatic challenges, including: (1) the non-transfusional agent desmopressin; (2) antifibrinolytic therapy; and (3) purified blood products that contain factor VIII and Von Willebrand factor concentrated from plasma. Additional treatment modalities include estrogen-progesterone preparations that are frequently adjunctive and can be an alternative to the main lines of treatment.
- Subjects
MENORRHAGIA treatment; DISEASE prevalence; VON Willebrand disease; BLOOD coagulation disorders; MENSTRUATION disorders; TEENAGE girls' health; QUALITY of life; HEMOSTASIS; VON Willebrand factor
- Publication
Journal of Coagulation Disorders, 2010, Vol 2, Issue 2, p1
- ISSN
2041-7969
- Publication type
Article